DexCare Acquires Mila Health to Bolster AI Patient Scheduling

Seattle, WA – September 21, 2026 – DexCare, a leading health-tech startup based in Seattle, today announced its acquisition of fellow local company Mila Health. The strategic move aims to significantly expand DexCare's AI-driven patient scheduling and care coordination capabilities, integrating Mila Health's specialized AI agents into its robust patient-access platform.

Mila Health has developed sophisticated AI agents capable of automating patient communications, including calls and texts, for medical appointment scheduling. This technology addresses a critical need in healthcare by streamlining administrative tasks and enhancing efficiency for providers and payers.

The terms of the acquisition were not disclosed by either company. However, the deal signifies a notable expansion for DexCare, which currently serves an impressive 57 million patients nationwide through its platform, boasting major customers like Kaiser Permanente, Piedmont, Texas Health Resources, and Tampa General.

DexCare, originally a spinout from Providence’s digital innovation group a decade ago, focuses on optimizing digital patient acquisition by expertly coordinating health system capacity with appointment booking. The company has demonstrated strong growth, having raised $146 million in total funding, including a substantial $75 million round in 2023. This marks their second acquisition, following the purchase of Womp, an e-commerce platform, in 2022.

Strategic Synergy in Healthcare AI

The integration of Mila Health's technology is expected to enhance DexCare's ability to manage patient referrals, insurance verification, and complex scheduling protocols more effectively. Mila’s rapid deployment capability, allowing its AI agents to be embedded into existing systems within hours, was a key factor in the acquisition.

Shailu Verma, co-founder and CEO of Mila Health, emphasized the importance of specialized AI in healthcare. “Healthcare can’t rely on out-of-the-box large language models because they’re unpredictable and can’t be audited,” Verma stated. He added that the combination with DexCare will enable providers and payers to configure AI agents for tasks they are unable to staff.

DexCare CEO Matt Blosl echoed this sentiment, highlighting the challenges health systems face in adopting AI. “AI solutions are everywhere, but health systems quickly realize that building the infrastructure, scaling the pilot, and managing the agent’s boundaries is untenable,” Blosl noted, underscoring the value of Mila’s tailored and auditable approach.

Company Backgrounds

DexCare is a prominent player in the Pacific Northwest startup scene, ranked No. 43 on the GeekWire 200 index of top regional startups. The company currently employs approximately 133 individuals, according to PitchBook data. Its innovative work was recognized as a finalist for Health Innovation of the Year at the 2023 GeekWire Awards.

Mila Health, though a younger startup launched in January 2024, quickly made an impact with its specialized AI. Shailu Verma brought extensive experience to Mila, previously serving as chief product officer of strategy and innovation at UnitedHealth Group and spending five years as a product manager at Amazon Web Services. Mila Health has 25 employees and participated in the Advanced Technology Development Center accelerator, though it does not appear to have raised venture capital prior to this acquisition.

This acquisition represents a significant step forward in leveraging specialized AI to tackle the complexities of patient access and care coordination within the healthcare industry. By combining DexCare's broad platform with Mila Health's targeted AI agents, the unified entity is poised to offer a more comprehensive and efficient solution for healthcare organizations nationwide.

FAQ

Q: What is the primary purpose of DexCare acquiring Mila Health? A: DexCare acquired Mila Health to expand its AI patient scheduling and care coordination capabilities. Mila Health's AI agents automate patient calls and texts for appointments, which will be integrated into DexCare's platform to enhance efficiency and address staffing challenges in healthcare organizations.

Q: What specific technology does Mila Health bring to DexCare? A: Mila Health brings AI agents designed to automate patient communications related to appointment scheduling, including answering questions about availability and patient qualifications. This technology can be rapidly deployed into existing systems, taking only hours to embed and launch.

Q: How does this acquisition benefit healthcare organizations and patients? A: The acquisition aims to benefit healthcare organizations by providing configurable and auditable AI agents that can handle tasks they are understaffed for, such as patient scheduling and communication. For patients, it is expected to streamline the process of booking appointments and navigating healthcare access, serving DexCare's existing base of 57 million patients nationwide with improved efficiency.